Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ex-Novartis Diagnostics President Assumes New Roles

This article was originally published in Scrip

Executive Summary

Gene Walther, who was previously Novartis' diagnostics president, has been appointed head of NetScientific Plc.'s diagnostics franchise and will become the CEO of the company's portfolio company, Vortex BioSciences – effective Jan. 4, 2016. Walther replaces Vortex BioSciences' interim CEO, Michael Boyce-Jacino, who will leave the company and board of directors at the end of December 2015. Most recently Walther was consultant to the Paul G. Allen Family Foundation. Prior to this he was deputy director, diagnostics for the Bill & Melinda Gates Foundation and he also served as executive chair of GenturaDx's board. Walther spent over a decade at Novartis as president and global head of diagnostics.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC063990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel